FGF23 and hyperphosphatemia: Among patients with ESRD, loss of renal function is often accompanied by hyperphosphatemia, deficiencies of 25-hydroxyvitamin D3 and/or 1,25-hydroxyvitamin D3, and increased levels of the phosphatonin fibroblast growth factor23 [21–23].